Details of the Drug

General Information of Drug (ID: DM7QG0M)

Drug Name

Raxibacumab

Indication

Disease Entry	ICD 11	Status	REF
Anthrax	1B97	Approved	[1]
------------------------------------------------------------------------------------

Affected Organisms

Gram-positive Bacteria

ATC Code

J06BC02: Raxibacumab

J06BC: Antibacterial monoclonal antibodies

J06B: IMMUNOGLOBULINS

J06: IMMUNE SERA AND IMMUNOGLOBULINS

J: ANTIINFECTIVES FOR SYSTEMIC USE

Drug Type

Monoclonal antibody

ADMET Property

Half-life: The concentration or amount of drug in body reduced by one-half in 15 - 19 days [2]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Bacterial Protective antigen (Bact pagA)	TT3YGCD	PAG_BACAN	Modulator	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011 Apr 1;186(7):4234-43.
2	Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds